Reconciling differences between EUCAST 'breakpoint-defining doses' and UK national antimicrobial treatment guidelines.

Jamieson C, Boyd SE, Wootton M, Livermore DM, Hand K, Macgowan AP, Howe RA, BSAC Standing Committee on Antimicrobial Susceptibility Testing

Open source

DOI: 10.1093/jac/dkag315
Published: 2026 Sep 1
Container: The Journal of antimicrobial chemotherapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jac/dkag315,
  title = {Reconciling differences between EUCAST 'breakpoint-defining doses' and UK national antimicrobial treatment guidelines.},
  author = {Jamieson C and Boyd SE and Wootton M and Livermore DM and Hand K and Macgowan AP and Howe RA and BSAC Standing Committee on Antimicrobial Susceptibility Testing},
  year = {2026},
  journal = {The Journal of antimicrobial chemotherapy},
  doi = {10.1093/jac/dkag315},
  url = {https://doi.org/10.1093/jac/dkag315}
}

RIS

TY  - JOUR
TI  - Reconciling differences between EUCAST 'breakpoint-defining doses' and UK national antimicrobial treatment guidelines.
AU  - Jamieson C
AU  - Boyd SE
AU  - Wootton M
AU  - Livermore DM
AU  - Hand K
AU  - Macgowan AP
AU  - Howe RA
AU  - BSAC Standing Committee on Antimicrobial Susceptibility Testing
PY  - 2026
JO  - The Journal of antimicrobial chemotherapy
DO  - 10.1093/jac/dkag315
UR  - https://doi.org/10.1093/jac/dkag315
ER  -

APA

C, J., SE, B., M, W., DM, L., K, H., AP, M., RA, H., & Testing, B. S. C. O. A. S. (2026). Reconciling differences between EUCAST 'breakpoint-defining doses' and UK national antimicrobial treatment guidelines.. The Journal of antimicrobial chemotherapy. https://doi.org/10.1093/jac/dkag315

Source records

pubmed · retrieved 2026-09-26T15:08:24.175Z